Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when KYNB files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: KYNB KYNTRA BIO, INC. 8-K

Kyntra Bio reports Q1 2026 financial results

Filed May 11, 2026 · Period ending May 11, 2026 · ~1 min read

1 key change 2 sections

Key Changes

  • medium

    Kyntra Bio issued a press release announcing financial results for the quarter ended March 31, 2026. Specific figures are contained in the attached press release (Exhibit 99.1), not in the 8-K body itself.

Summary

Kyntra Bio filed an 8-K to announce its first quarter 2026 financial results via press release on May 11, 2026. This is a routine quarterly earnings disclosure required by SEC regulations. The actual financial figures, operational updates, and management commentary are contained in the attached press release rather than in the 8-K filing itself.

Retail investors should review the full press release (Exhibit 99.1) to understand the company's revenue, expenses, cash position, and any forward-looking guidance for the remainder of 2026. Watch for any subsequent analyst calls or investor presentations that may provide additional context on the quarter's performance and strategic priorities.

Section-by-Section Diff

Event · Item 2.02 — Results of Operations and Financial Condition

~100 words

Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.

1 Added
Added Q1 2026 financial results medium

Added in current filing · verify on EDGAR →

On May 11, 2026, Kyntra Bio, Inc. (“Kyntra Bio”) issued a press release announcing financial results for the quarter ended March 31, 2026.

Kyntra Bio announced its financial results for the first quarter ended March 31, 2026. The 8-K itself does not contain the actual financial figures; those are in the attached press release (Exhibit 99.1). This is a standard earnings disclosure event.

Event · Item 9.01 — Financial Statements and Exhibits

~100 words

KYNTRA BIO filed an 8-K attaching a press release dated May 11, 2026; no material business event disclosed in the filing body.

1 Added
Added Press release attachment medium

Added in current filing · verify on EDGAR →

99.1 Press Release dated May 11, 2026

The company attached a press release dated May 11, 2026 as Exhibit 99.1. The 8-K body does not describe the content of the press release, so the nature and materiality of any disclosed event cannot be determined from this filing alone.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 10, 2026 · How we verify